Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 3 BTX-A treatment related to age, sex, and GMFCS level

From: Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study

Variable (reference group) Odds ratio (95% CIs)
Age (1–3 years of age)
 4–6 years of age 2.02 (1.57–2.61)
 7–9 years of age 1.53 (1.18–1.99)
 10–12 years of age 1.14 (0.87–1.50)
 13–15 years of age 0.81 (0.58–1.13)
Sex (Girls)
 Boys 1.25 (1.05–1.48)
GMFCS level (Level I)
 Level II 1.75 (1.37–2.24)
 Level III 2.59 (1.94–3.45)
 Level IV 2.58 (2.02–3.28)
 Level V 2.27 (1.77–2.92)
  1. The odds ratio and 95% CIs of children treated with BTX-A in relation to age, sex, and GMFCS level.
  2. BTX-A = Botulinum Toxin A.
  3. CIs = confidence intervals.
  4. GMFCS = Gross Motor Function Classification System.